News | September 23, 2024
Ind Swift Laboratories opens marketing office in New Delhi
This office will be the central hub for all operations related to companies ethical pharmaceutical business
This office will be the central hub for all operations related to companies ethical pharmaceutical business
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
This approval reflects company’s unwavering commitment that the quality assurance
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Stable profits, low leverage to keep credit profiles comfortable
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
Subscribe To Our Newsletter & Stay Updated
